8-53833024-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015941.4(ATP6V1H):c.176C>T(p.Pro59Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,558 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000018 ( 1 hom. )
Consequence
ATP6V1H
NM_015941.4 missense
NM_015941.4 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 5.98
Genes affected
ATP6V1H (HGNC:18303): (ATPase H+ transporting V1 subunit H) This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of intracellular organelles. V-ATPase-dependent organelle acidification is necessary for multiple processes including protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. The encoded protein is the regulatory H subunit of the V1 domain of V-ATPase, which is required for catalysis of ATP but not the assembly of V-ATPase. Decreased expression of this gene may play a role in the development of type 2 diabetes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.100268096).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP6V1H | NM_015941.4 | c.176C>T | p.Pro59Leu | missense_variant | 3/14 | ENST00000359530.7 | NP_057025.2 | |
ATP6V1H | NM_213620.3 | c.176C>T | p.Pro59Leu | missense_variant | 3/14 | NP_998785.1 | ||
ATP6V1H | NM_213619.3 | c.176C>T | p.Pro59Leu | missense_variant | 3/13 | NP_998784.1 | ||
ATP6V1H | XM_006716455.4 | c.176C>T | p.Pro59Leu | missense_variant | 3/13 | XP_006716518.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP6V1H | ENST00000359530.7 | c.176C>T | p.Pro59Leu | missense_variant | 3/14 | 1 | NM_015941.4 | ENSP00000352522.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152112Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
152112
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250948Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135656
GnomAD3 exomes
AF:
AC:
9
AN:
250948
Hom.:
AF XY:
AC XY:
3
AN XY:
135656
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461446Hom.: 1 Cov.: 30 AF XY: 0.0000206 AC XY: 15AN XY: 727002
GnomAD4 exome
AF:
AC:
27
AN:
1461446
Hom.:
Cov.:
30
AF XY:
AC XY:
15
AN XY:
727002
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152112Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74300
GnomAD4 genome
AF:
AC:
2
AN:
152112
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74300
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
6
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2022 | The c.176C>T (p.P59L) alteration is located in exon 3 (coding exon 2) of the ATP6V1H gene. This alteration results from a C to T substitution at nucleotide position 176, causing the proline (P) at amino acid position 59 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;N;N;.;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;D;D
REVEL
Uncertain
Sift
Benign
T;D;D;D;D;D
Sift4G
Benign
T;T;T;T;T;.
Polyphen
B;.;B;B;.;.
Vest4
MutPred
Loss of glycosylation at P59 (P = 0.0077);.;Loss of glycosylation at P59 (P = 0.0077);Loss of glycosylation at P59 (P = 0.0077);Loss of glycosylation at P59 (P = 0.0077);Loss of glycosylation at P59 (P = 0.0077);
MVP
MPC
0.29
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at